Literature DB >> 10759217

Molecular mechanism of the reversibility of hepatic fibrosis: with special reference to the role of matrix metalloproteinases.

I Okazaki1, T Watanabe, S Hozawa, M Arai, K Maruyama.   

Abstract

The participation of matrix metalloproteinases (MMP) and their specific inhibitors, the tissue inhibitors of matrix metalloproteinases (TIMP), in both the formation and degradative recovery processes of liver fibrosis were mainly reviewed from the molecular biological aspect. Since authors first reported increased activity of interstitial collagenase in the early stage of hepatic fibrosis in rats induced by chronic CCl4 intoxication, in baboons fed alcohol chronically and in patients with alcoholic fibrosis, other investigators have also demonstrated increased activity biologically and histochemically. However, species-specific differences in response have been found and gene-level research on the rat model has not demonstrated increased mRNA transcription of collagenase. It has also been clarified that activated stellate cells can also produce matrix components. Very recently, authors observed the participation of interstitial collagenase in the recovery from experimental hepatic fibrosis by using polymerase chain reaction northern blotting and in situ hybridization. The in situ hybridization findings not only demonstrated the cells responsible for interstitial collagenase, but also suggested a great deal about the mechanism of recovery from fibrosis. Hepatic stellate cells are activated via the expression of c-myb and nuclear factor-kappaB (NFkappaB) which is induced by oxidative stress, and inhibited by antioxidant (1-alpha-tocopherol) and butylated hydroxytoluene. The activation mechanism is now being revealed. The relationship between the activation mechanism of stellate cells and the production and secretion of MMP and TIMP in the formation and recovery process of hepatic fibrosis should be investigated from the promoter gene level. This approach might help develop a new strategy for the treatment of liver fibrosis.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10759217     DOI: 10.1046/j.1440-1746.2000.02185.x

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  19 in total

1.  Ginkgo biloba extract reverses CCl4-induced liver fibrosis in rats.

Authors:  Yan-Jun Luo; Jie-Ping Yu; Zhao-Hong Shi; Li Wang
Journal:  World J Gastroenterol       Date:  2004-04-01       Impact factor: 5.742

2.  Zinc mediated hepatic stellate cell collagen synthesis reduction through TGF-β signaling pathway inhibition.

Authors:  Min Kang; Lei Zhao; Meiping Ren; Mingming Deng; Changping Li
Journal:  Int J Clin Exp Med       Date:  2015-11-15

3.  Expression of tissue inhibitor of matrix metalloproteinases-1 during aging in rat liver.

Authors:  Yu-Mei Zhang; Xiang-Mei Chen; Di Wu; Suo-Zhu Shi; Zhong Yin; Rui Ding; Yang Lü
Journal:  World J Gastroenterol       Date:  2005-06-28       Impact factor: 5.742

4.  Inhibitory effects of saikosaponin-d on CCl4-induced hepatic fibrogenesis in rats.

Authors:  Shuang-Suo Dang; Bao-Feng Wang; Yan-An Cheng; Ping Song; Zhen-Guo Liu; Zong-Fang Li
Journal:  World J Gastroenterol       Date:  2007-01-28       Impact factor: 5.742

5.  Increased ADAMTS-13 proteolytic activity in rat hepatic stellate cells upon activation in vitro and in vivo.

Authors:  M Niiya; M Uemura; X W Zheng; E S Pollak; M Dockal; F Scheiflinger; R G Wells; X L Zheng
Journal:  J Thromb Haemost       Date:  2006-05       Impact factor: 5.824

6.  Effect of Astragalus complanatus flavonoid on anti-liver fibrosis in rats.

Authors:  Chun-Yu Liu; Zhen-Lun Gu; Wen-Xuan Zhou; Ci-Yi Guo
Journal:  World J Gastroenterol       Date:  2005-10-07       Impact factor: 5.742

7.  Plasminogen deficiency leads to impaired lobular reorganization and matrix accumulation after chronic liver injury.

Authors:  J F Pohl; H Melin-Aldana; G Sabla; J L Degen; J A Bezerra
Journal:  Am J Pathol       Date:  2001-12       Impact factor: 4.307

8.  Production of pro- and anti-fibrotic agents by rat Kupffer cells; the effect of octreotide.

Authors:  Costas Xidakis; Dushanka Ljumovic; Pinelopi Manousou; George Notas; Vassilis Valatas; George Kolios; Elias Kouroumalis
Journal:  Dig Dis Sci       Date:  2005-05       Impact factor: 3.199

9.  Inhibitory effect of Huangqi Zhechong decoction on liver fibrosis in rat.

Authors:  Shuang-Suo Dang; Xiao-Li Jia; Yan-An Cheng; Yun-Ru Chen; En-Qi Liu; Zong-Fang Li
Journal:  World J Gastroenterol       Date:  2004-08-01       Impact factor: 5.742

10.  Gene expression profiling of alcoholic liver disease in the baboon (Papio hamadryas) and human liver.

Authors:  Devanshi Seth; Maria A Leo; Peter H McGuinness; Charles S Lieber; Yvonne Brennan; Rohan Williams; Xin M Wang; Geoffrey W McCaughan; Mark D Gorrell; Paul S Haber
Journal:  Am J Pathol       Date:  2003-12       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.